Performance Analysis And Enlightenment Of Fosun Pharma M&A Alma Lasers Company

Since the 21 st century,with the rapid growth of China's economy,China's position in the global economy gradually increased,China's pharmaceutical market has become second only to the world's second largest pharmaceutical market.Some of our pharmaceutical companies have gradually moved to the international market,began in the global layout.Recently,with the emergence of overseas mergers and acquisitions of pharmaceutical companies,people are increasingly concerned about the ability of overseas mergers and acquisitions can create value,and cross-border M & A behavior on business performance impact.Fosun Pharma listed companies through the development of mergers and acquisitions,and its growth in the process of many domestic and foreign mergers and acquisitions,cross-border mergers and acquisitions have accumulated rich experience.In 2016,Fosun Pharma spent $ 1.4 billion to buy India's Gland.In the end what causes the Fosun Pharma to continue overseas acquisitions.What does this mean in the end? Whether mergers and acquisitions can create value for the enterprise.In this paper,Fosun Pharma merged Israel Alma Lasers company as an example to discuss the reasons for mergers and acquisitions and integration effect.On this basis,further analysis of this successful case for China's pharmaceutical companies overseas mergers and acquisitions and strategic integration to provide relevant experience and inspiration.